Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 78,254 | 78,332 | 57,090 | 45,389 | 37,620 |
| Depreciation Amortization | 24,369 | 18,427 | 18,897 | 20,124 | 22,229 |
| Income taxes - deferred | -4,477 | N/A | -1,192 | 3,815 | -380 |
| Accounts receivable | -9,300 | -5,162 | -5,567 | 7,800 | 5,007 |
| Accounts payable and accrued liabilities | 4,901 | -5,791 | 9,560 | -1,590 | -2,750 |
| Other Working Capital | 10,745 | -13,637 | 21,818 | 27,279 | -16,687 |
| Other Operating Activity | 12,060 | 23,210 | 16,549 | 436 | 1,325 |
| Operating Cash Flow | $116,552 | $95,379 | $117,155 | $103,253 | $46,364 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 44,261 | 48,896 | -65,812 | -28,864 | -4,639 |
| PPE Investments | -21,448 | -29,065 | -16,896 | -15,087 | -17,381 |
| Purchase Sale Intangibles | -7,604 | -53,942 | -2,300 | -375 | N/A |
| Other Investing Activity | -10,219 | -56,582 | -5,024 | -2,819 | -4,210 |
| Investing Cash Flow | $12,594 | $-36,751 | $-87,732 | $-46,770 | $-26,230 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -356 | N/A | N/A | N/A |
| Common Stock Issued | 18,841 | 19,376 | 31,165 | 11,949 | 14,044 |
| Common Stock Repurchased | -123,769 | -129,191 | -35,817 | -29,830 | -12,986 |
| Other Financing Activity | -2,057 | 0 | -510 | -7,462 | -144 |
| Financing Cash Flow | $-106,985 | $-110,171 | $-5,162 | $-25,343 | $914 |
| Exchange Rate Effect | -2,166 | 1,757 | 3,168 | 2,007 | -389 |
| Beginning Cash Position | 47,156 | 96,942 | 69,513 | 36,366 | 46,007 |
| End Cash Position | 67,151 | 47,156 | 96,942 | 69,513 | 66,666 |
| Net Cash Flow | $19,995 | $-49,786 | $27,429 | $33,147 | $20,659 |
| Free Cash Flow | |||||
| Operating Cash Flow | 116,552 | 95,379 | 117,155 | 103,253 | 46,364 |
| Capital Expenditure | -24,199 | -29,065 | -16,896 | -15,087 | -17,381 |
| Free Cash Flow | 92,353 | 66,314 | 100,259 | 88,166 | 28,983 |